Oyler John

BeOne Medicines Ltd. · Chief Executive Officer

Oyler John is listed in filings as Chief Executive Officer at BeOne Medicines Ltd.. This profile follows SEC Form 4 activity through Jun 15, 2026, including sale activity. Recent filings connect the profile to BeOne Medicines Ltd. (ONC) and BeiGene Ltd (BGNE). The current snapshot covers public activity from Mar 7, 2025 to Jun 15, 2026. Reported amounts are shown as $7.2M to $51.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceLast Price
BeiGene LtdBGNE$3M12.6k sharesSellMar 7, 2025$249.97$184.71
BeiGene LtdBGNE$2M8.9k sharesSellMar 7, 2025$249.04$184.71
BeiGene LtdBGNE$2M7.6k sharesSellMar 7, 2025$247.99$184.71
BeiGene LtdBGNE$3M13.9k sharesSellMar 7, 2025$246.91$184.71
BeiGene LtdBGNE$294k1.2k sharesSellMar 7, 2025$246.69$184.71
BeiGene LtdBGNE$517k2.1k sharesSellMar 7, 2025$246.10$184.71
BeiGene LtdBGNE$344k1.4k sharesSellMar 7, 2025$246.03$184.71
BeiGene LtdBGNE$173k700 sharesSellMar 10, 2025$246.85$184.71
BeiGene LtdBGNE$1M4.9k sharesSellMar 10, 2025$246.11$184.71
BeiGene LtdBGNE$737k3k sharesSellMar 10, 2025$245.19$184.71
BeiGene LtdBGNE$1M5.3k sharesSellMar 10, 2025$244.04$184.71
BeiGene LtdBGNE$2M9.3k sharesSellMar 10, 2025$243.04$184.71
BeiGene LtdBGNE$2M7.1k sharesSellMar 10, 2025$241.92$184.71
BeiGene LtdBGNE$530k2.2k sharesSellMar 10, 2025$240.70$184.71
BeiGene LtdBGNE$2M6.8k sharesSellMar 10, 2025$239.59$184.71
BeiGene LtdBGNE$454k1.9k sharesSellMar 10, 2025$238.74$184.71
Showing 51-66 of 66